Skip to content

INDV

Indivior Pharmaceuticals, Inc.

Stock

$35.71+0.33 (+0.93%)Close Oct 2, 2026

Operating cash flow, 2025
−$27M

Operating cash flow

Operating cash flow by fiscal year

PeriodOperating cash flowYoY
2025−$27M—
2024$36M—
2023−$300M—
2022−$4.0M—